Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity.
Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity.
复制标题
细胞穿透肽作为形态寡聚物的转运蛋白:氨基酸组成对细胞内递送和细胞毒性的影响。
DOI:
10.1093/nar/gkm478
复制
发表时间:
2007
影响因子:
14.9
通讯作者:
Moulton HM
中科院分区:
文献类型:
--
作者:
Wu RP;Youngblood DS;Hassinger JN;Lovejoy CE;Nelson MH;Iversen PL;Moulton HM
Arginine-rich cell-penetrating peptides (CPPs) are promising transporters for intracellular delivery of antisense morpholino oligomers (PMO). Here, we determined the effect of L-arginine, D-arginine and non-α amino acids on cellular uptake, splice-correction activity, cellular toxicity and serum binding for 24 CPP−PMOs. Insertion of 6-aminohexanoic acid (X) or β-alanine (B) residues into oligoarginine R8 decreased the cellular uptake but increased the splice-correction activity of the resulting compound, with a greater increase for the sequences containing more X residues. Cellular toxicity was not observed for any of the conjugates up to 10 μM. Up to 60 μM, only the conjugates with ⩾ 5 Xs exhibited time- and concentration-dependent toxicity. Substitution of L-arginine with D-arginine did not increase uptake or splice-correction activity. High concentration of serum significantly decreased the uptake and splice-correction activity of oligoarginine conjugates, but had much less effect on the conjugates containing X or B. In summary, incorporation of X/B into oligoarginine enhanced the antisense activity and serum-binding profile of CPP−PMO. Toxicity of X/B-containing conjugates was affected by the number of Xs, treatment time and concentration. More active, stable and less toxic CPPs can be designed by optimizing the position and number of R, D-R, X and B residues.
登录
查看更多内容
影响因子:
5.1
作者:
McClorey, G.;Moulton, H. M.;Wilton, S. D.
通讯作者:
Wilton, S. D.
DOI:
10.1089/108729003764097322
发表时间:
2003-02-01
期刊:
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
影响因子:
--
作者:
Moulton, HM;Hase, MC;Iversen, PL
通讯作者:
Iversen, PL
影响因子:
2.8
作者:
McClorey, G.;Fall, A. M.;Wilton, S. D.
通讯作者:
Wilton, S. D.
影响因子:
5.4
作者:
Deas, TS;Binduga-Gajewska, I;Shi, PY
通讯作者:
Shi, PY
影响因子:
2.9
作者:
Kang, SH;Cho, MJ;Kole, R
通讯作者:
Kole, R